Presence of vasoconstrictor 5HT1‐like receptors revealed by precontraction of rabbit isolated mesenteric artery
Authors:
Open Access
- 1 January 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 114 (2) , 309-314
Abstract
A series of 5‐hydroxytryptamine (5‐HT) receptor agonists including 5‐HT, 5‐carboxamidotryptamine (5‐CT) and sumatriptan produced little or no contraction of rabbit isolated mesenteric arteries under resting tone conditions, even at concentrations up to 10−4m. When the same agonists were retested in mesenteric artery preparations pre‐contracted with the thromboxane‐mimetic, U46619, each demonstrated concentration‐related vasoconstrictor activity. 5‐CT and 5‐HT were especially potent and effective in this model giving EC50values of 4.3 times 10−9mand 1.6 times 10−8mrespectively and maximum effects equivalent to those of KC1 80 mm. In preparations precontracted by U46619 (conditions retained throughout the rest of the study) the order of agonist potency was 5‐CT>5‐HT>RU 24969 = sumatriptan>8‐hydroxy‐2‐(di‐n‐propylamino)tetralin (8‐OHDPAT) > cisapride. The vasoconstrictor effects of 5‐CT were competitively antagonized by methiothepin (pA28.20) but resistant to antagonism by a range of other 5‐HT receptor antagonists, i.e. pindolol (5‐HT1A/5‐HT1B), propranolol (5‐HT1B), spiperone (5‐HT2A), ondansetron (5‐HT3), ICS 205930 (5‐HT3/5‐HT4) and SDZ 205557 (5‐HT4). 5‐CT responses were slightly antagonized by a high concentration of ritanserin (5‐HT2A/5‐HT2C). Responses to 5‐HT and sumatriptan were also antagonized by methiothepin with similar affinity (pA2/pKBvalues ⋍ 8.0). Metergoline and rauwolscine (10−7−10−6m) antagonized the effects of 5‐CT in a non‐competitive fashion giving pKBappvalues of 7.13 (metergoline) and 6.86 (rauwolscine). Vasoconstrictor responses to 5‐HT were not modified in the presence of ritanserin (3 times 10−7m) or spiperone (3 times 10−7m) and only modestly antagonized by ketanserin (10−6m) suggesting that 5‐HT2Areceptors do not make a significant contribution in this model. Hence, precontraction of rabbit mesenteric arteries reveals potent vasoconstrictor effects of 5‐HT and related agonists. Based on the agonist potency order and the antagonist studies performed, the receptor subtype responsible has the characteristics of a 5‐HT1‐like (probably 5‐HT1D) receptor. This study therefore demonstrates a particularly striking example of vasoconstrictor synergy involving 5‐HT1‐like receptors.Keywords
This publication has 24 references indexed in Scilit:
- Human arterial constrictor serotonin receptorsCardiovascular Research, 1993
- Comparison of contractile responses to 5‐hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2‐receptor agonist, U46619British Journal of Pharmacology, 1993
- A proposed new nomenclature for 5-HT receptorsTrends in Pharmacological Sciences, 1993
- Pre-contraction with histamine and U46619 unmasks a 5-HT1-like receptor in rabbit renal arteryEuropean Journal of Pharmacology, 1993
- Contractile 5‐HT1 receptors in human isolated pial arterioles: correlation with 5‐HT1D binding sitesBritish Journal of Pharmacology, 1991
- 5-HT Receptors: Subtypes and Second MessengersJournal of Receptor Research, 1991
- Characterization of 5‐HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5‐HT1‐like receptor agonistBritish Journal of Pharmacology, 1989
- GR43175, a selective agonist for the 5‐HT1‐like receptor in dog isolated saphenous veinBritish Journal of Pharmacology, 1988
- Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamineNeuropharmacology, 1986
- RECEPTOR MECHANISMS FOR 5‐HYDROXYTRYPTAMINE IN RABBIT ARTERIESBritish Journal of Pharmacology, 1981